About the Authors
- Rafael Fenutría
-
Contributed equally to this work with: Rafael Fenutría, Vanesa G. Martinez
Affiliation Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Vanesa G. Martinez
-
Contributed equally to this work with: Rafael Fenutría, Vanesa G. Martinez
Affiliation Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Inês Simões
-
Affiliation Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Jorge Postigo
-
Affiliation Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain
- Victor Gil
-
Affiliation Servei de Malalties Autoimmunes Sistémiques, Hospital Clínic de Barcelona, Barcelona, Spain
- Mario Martínez-Florensa
-
Affiliation Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Jordi Sintes
-
Affiliation Departament de Biologia Cel·lular, Immunologia i Neurociències, Universitat de Barcelona, Barcelona, Spain
- Rodrigo Naves
-
Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Kevin S. Cashman
-
Affiliation Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- José Alberola-Ila
-
Affiliation Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America
- Manel Ramos-Casals
-
Affiliation Servei de Malalties Autoimmunes Sistémiques, Hospital Clínic de Barcelona, Barcelona, Spain
- Gloria Soldevila
-
Affiliation Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Distrito Federal, México
- Chander Raman
-
Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Jesús Merino
-
Affiliation Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain
- Ramón Merino
-
Affiliations Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain, Instituto de Biomedicina y Biotecnología de Cantabria, Consejo Superior de Investigaciones Científicas-Universidad de Cantabria-SODERCAN, Santander, Spain
- Pablo Engel
-
Affiliation Departament de Biologia Cel·lular, Immunologia i Neurociències, Universitat de Barcelona, Barcelona, Spain
- Francisco Lozano
-
* E-mail: flozano@clinic.ub.es
Affiliations Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, Departament de Biologia Cel·lular, Immunologia i Neurociències, Universitat de Barcelona, Barcelona, Spain, Servei d'Immunologia, Hospital Clínic de Barcelona, Barcelona, Spain
Competing Interests
The authors hereby declare that even though this work has been the base for an application for a European Patent (No. n°: 11382172.2 “New compounds derived from scavenger-like lymphocyte receptors for use in immunotherapy”), it does not alter their adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RF VGM JM RM MRC CR GS JAI PE FL. Performed the experiments: RF VGM IS JP VG MMF JS RN KSC JM RM. Analyzed the data: RF VGM IS JP MRC JM RM JAI CR GS PE FL. Contributed reagents/materials/analysis tools: JM RM CR PE. Wrote the paper: RF VGM MRC JM RM JAI CR GS PE FL.